Patterns of care in oligometastatic disease: the clinicians’ perspective

Figures & data

Figure 1. The preferred threshold of metastases/organs eligible for an ablative strategy in patients with OMD. (A) The preferred threshold of metastases (mets), the responders were willing to treat when applying an ablative strategy in patients with OMD. (B) The preferred threshold of involved organs (org), the responders were willing to treat when applying an ablative strategy in patients with OMD.

Figure 2. The need for tumor board discussion; (A) do you think all patients with OMD should be discussed at a tumor board before referred to SBRT? (B) Are all patients with OMD discussed at a tumor board before referred to SBRT?

Data availability statement

The data that support the findings of this study are available from the corresponding author, Mette van Overeem Felter, upon reasonable request.